Literature DB >> 17478764

BRAF T1799A mutation occurring in a case of malignant struma ovarii.

Richard Flavin1, Paul Smyth, Paul Crotty, Stephen Finn, Susanne Cahill, Karen Denning, Esther O'Regan, John O'Leary, Orla Sheils.   

Abstract

Struma ovarii is an extremely rare tumor that occasionally undergoes malignant transformation. Because struma ovarii is composed of thyroid tissue, it is conceivable that the pathogenetic events involved in thyroid follicular transformation may take place also in struma ovarii. The authors describe a case of a classical variant of papillary thyroid carcinoma arising in a struma ovarii of a 22-year-old female. The tumor was heterozygous for BRAF T1799A mutation. No ret/ PTC-1 or ret/PTC-3 rearrangements were detected. This finding would suggest that malignant struma ovarii is similar histologically and genetically to primary papillary thyroid carcinoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17478764     DOI: 10.1177/1066896906299131

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  12 in total

Review 1.  Selective Raf inhibition in cancer therapy.

Authors:  Vladimir Khazak; Igor Astsaturov; Ilya G Serebriiskii; Erica A Golemis
Journal:  Expert Opin Ther Targets       Date:  2007-12       Impact factor: 6.902

2.  Pancreatic Struma with Papillary Thyroid Carcinoma: a Diagnostic Dilemma.

Authors:  Jerry Liu; Michael J Marcaccio; J E M Young; Tariq Aziz; Josephine Wat; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2017-03       Impact factor: 3.943

Review 3.  Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a BRAF-positive follicular variant of papillary thyroid cancer.

Authors:  Erin F Wolff; Marybeth Hughes; Maria J Merino; James C Reynolds; Jeremy L Davis; Craig S Cochran; Francesco S Celi
Journal:  Thyroid       Date:  2010-09       Impact factor: 6.568

4.  A case of papillary thyroid carcinoma in struma ovarii and review of the literature.

Authors:  W D Salman; Mayuri Singh; Z Twaij
Journal:  Patholog Res Int       Date:  2010-08-02

5.  Novel BRAF and KRAS Mutations in Papillary Thyroid Carcinoma Arising in Struma Ovarii.

Authors:  A Tan; C J R Stewart; K L Garrett; M Rye; P A Cohen
Journal:  Endocr Pathol       Date:  2015-12       Impact factor: 3.943

6.  RAS mutation-positive follicular variant of papillary thyroid carcinoma arising in a struma ovarii.

Authors:  Christopher Coyne; Yuri E Nikiforov
Journal:  Endocr Pathol       Date:  2010-06       Impact factor: 3.943

7.  Follicular variant papillary thyroid carcinoma arising in struma ovarii.

Authors:  Odette Boutross-Tadross; Remaa Saleh; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

8.  Unilateral follicular variant of papillary thyroid carcinoma with unique KRAS mutation in struma ovarii in bilateral ovarian teratoma: a rare case report.

Authors:  Boban Stanojevic; Radan Dzodic; Vladimir Saenko; Zorka Milovanovic; Vesna Krstevski; Petar Radlovic; Marko Buta; Bozidar Rulic; Lidija Todorovic; Bogomir Dimitrijevic; Shunichi Yamashita
Journal:  BMC Cancer       Date:  2012-06-08       Impact factor: 4.430

9.  Papillary Thyroid Microcarcinoma Arising Within a Mature Ovarian Teratoma: Case Report and Review of the Literature.

Authors:  Maria M Pineyro; Jimena Pereda; Pamela Schou; Karina de Los Santos; Soledad de la Peña; Benedicta Caserta; Raul Pisabarro
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2017-06-06

10.  Extensive peritoneal implant metastases of malignant struma ovarii treated by thyroidectomy and 131I therapy: A case report.

Authors:  Mengxue Wu; Fengqiong Hu; Xing Huang; Zuwen Tan; Chengming Lei; Dong Duan
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.